A complete tumor disappearance was observed 30 days after an intratumor injection of anti-GPC3-7 × 19 CAR-T treatment in a patient with advanced HCC enrolled in an ongoing phase 1 clinical trial (NCT03198546) [46]. The gene discussed is GPC3; the disease is neoplasm.